Crianza de animales domésticos como factor de riesgo de fascioliasis humana

The aim of this study was to determine the association of fascioliasis with the breeding of animals, housing characteristics and food consumption of children in the district of Santa María de Chicmo, Apurimac, Peru. Serological samples were taken from 493 children aged 6 to 16 years, males and females, with the informed consent of their parents. The prevalence, determined by the immunoblot technique was 5.3% (95% CI = 3.2% -7.4%, 26/493). The univariate analysis showed that the breeding of cattle and cats, and raising three or more pigs were factors associated with fascioliasis. The breeding of more than five sheep resulted as a protection factor. Fascioliasis in children was not associated with the characteristics of the dwellings or the consumption of food. It is concluded that the district of Santa María de Chicmo is mesoendemic for fascioliasis in children, and that the rearing of some species of domestic animals involves risk of human fascioliasis.  El estudio tuvo como objetivo determinar la asociación de fascioliasis con la crianza de animales, características de la vivienda y consumo de alimentos de niños del distrito de Santa María de Chicmo, Apurímac, Perú. Se tomaron muestras serológicas a 493 niños de 6 a 16 años, de ambos sexos, con el consentimiento informado de sus padres. La prevalencia, determinada mediante la técnica de inmunoblot fue de 5.3% (IC95%=3.2%-7.4%; 26/493). El análisis univariado demostró que la crianza de bovinos y gatos, así como la crianza de tres o más cerdos fueron factores asociados a fascioliasis. La crianza de más de cinco ovinos configuró un factor de protección. La fascioliasis en niños no estuvo asociada a las características de las viviendas ni al consumo de alimentos. Se concluye que el distrito de Santa María de Chicmo es mesoendémico para fascioliasis en niños, y que la crianza de algunas especies de animales domésticos implica riesgo de fascioliasis humana

Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes.

OBJECTIVE: Proinsulin is a precursor of mature insulin and C-peptide. Higher circulating proinsulin levels are associated with impaired β-cell function, raised glucose levels, insulin resistance, and type 2 diabetes (T2D). Studies of the insulin processing pathway could provide new insights about T2D pathophysiology. RESEARCH DESIGN AND METHODS: We have conducted a meta-analysis of genome-wide association tests of ∼2.5 million genotyped or imputed single nucleotide polymorphisms (SNPs) and fasting proinsulin levels in 10,701 nondiabetic adults of European ancestry, with follow-up of 23 loci in up to 16,378 individuals, using additive genetic models adjusted for age, sex, fasting insulin, and study-specific covariates. RESULTS: Nine SNPs at eight loci were associated with proinsulin levels (P < 5 × 10(-8)). Two loci (LARP6 and SGSM2) have not been previously related to metabolic traits, one (MADD) has been associated with fasting glucose, one (PCSK1) has been implicated in obesity, and four (TCF7L2, SLC30A8, VPS13C/C2CD4A/B, and ARAP1, formerly CENTD2) increase T2D risk. The proinsulin-raising allele of ARAP1 was associated with a lower fasting glucose (P = 1.7 × 10(-4)), improved β-cell function (P = 1.1 × 10(-5)), and lower risk of T2D (odds ratio 0.88; P = 7.8 × 10(-6)). Notably, PCSK1 encodes the protein prohormone convertase 1/3, the first enzyme in the insulin processing pathway. A genotype score composed of the nine proinsulin-raising alleles was not associated with coronary disease in two large case-control datasets. CONCLUSIONS: We have identified nine genetic variants associated with fasting proinsulin. Our findings illuminate the biology underlying glucose homeostasis and T2D development in humans and argue against a direct role of proinsulin in coronary artery disease pathogenesis

Reducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries

Abstract Background Healthcare cannot achieve net-zero carbon without addressing operating theatres. The aim of this study was to prioritize feasible interventions to reduce the environmental impact of operating theatres. Methods This study adopted a four-phase Delphi consensus co-prioritization methodology. In phase 1, a systematic review of published interventions and global consultation of perioperative healthcare professionals were used to longlist interventions. In phase 2, iterative thematic analysis consolidated comparable interventions into a shortlist. In phase 3, the shortlist was co-prioritized based on patient and clinician views on acceptability, feasibility, and safety. In phase 4, ranked lists of interventions were presented by their relevance to high-income countries and low–middle-income countries. Results In phase 1, 43 interventions were identified, which had low uptake in practice according to 3042 professionals globally. In phase 2, a shortlist of 15 intervention domains was generated. In phase 3, interventions were deemed acceptable for more than 90 per cent of patients except for reducing general anaesthesia (84 per cent) and re-sterilization of ‘single-use’ consumables (86 per cent). In phase 4, the top three shortlisted interventions for high-income countries were: introducing recycling; reducing use of anaesthetic gases; and appropriate clinical waste processing. In phase 4, the top three shortlisted interventions for low–middle-income countries were: introducing reusable surgical devices; reducing use of consumables; and reducing the use of general anaesthesia. Conclusion This is a step toward environmentally sustainable operating environments with actionable interventions applicable to both high– and low–middle–income countries

Textualización de las reflexiones críticas realizadas por el estudiantado de tercer nivel de la carrera de Bachillerato en Danza durante el I Ciclo, 2021

La presente memoria de textualizaciones reflexivas del estudiantado de III Nivel de la carrera de Bachillerato en Danza tiene como propósito comunicar los aprendizajes logrados durante I Ciclo 2021, en el curso DAC 418 Reflexiones Críticas sobre el Cuerpo y la Danza, a partir de los intereses particulares de investigación de las personas participantes, pasiones atravesadas por sus cuerpos y sentires. Esto permitió realizar un ejercicio reflexivo profundo, sobre sus propias disposiciones emocionales, psíquicas y lógicas sobre la danza, inquietudes que fueron estructuradas y jerarquizadas a partir de hilos temáticos y significantes sociales, que partieron de búsquedas especializadas sobre conceptos claves, desarrolladas por medio de análisis multidimensionales, que finalizaron en enunciados propios y relevantes para su crecimiento académico y profesional. Además, este proceso reflexivo teórico se articuló con los saberes prácticos que se desarrollan en el curso DAC414 Técnica de Danza Contemporánea III, en donde, a partir del trabajo técnico sobre el cuerpo y las exploraciones grupales se logró profundizar en los contenidos del curso, validando experiencias y vivencias del estudiantado que permitieron contrastar y reflexionar las reflexiones críticas desde la teoría y la práctica de la Danza Contemporánea. Todo ello, detona en exploraciones temáticas por medio del cuerpo, en primera persona y en colectivo, así como, ahondar en todos los componentes del arte, en general. De esta manera, cada grupo de estudiantes ha escogido una sesión de clase práctica del curso DAC414 Técnica de Danza Contemporánea III, que representa su reflexión corporal y textual, para vincular ambos procesos de construcción de conocimiento, de naturalezas heterogéneas, y que las personas lectoras pueden tener acceso por medio de un enlace, al inicio de cada artículo académico. Esperamos que esta memoria de cuenta del complejo trabajo reflexivo logrado por el estudiantado participante y que permita a las personas lectoras hacer visibles las conexiones interdisciplinarias, entre diversas narrativas textuales (ciencias sociales, política, género, movimiento humano, etc.), así como los procesos de reflexión teórico – prácticos, a partir de los mecanismos de articulación de actividades entre cursos de la carrera.Escuela de Danz

Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes

OBJECTIVE - Proinsulin is a precursor of mature insulin and C-peptide. Higher circulating proinsulin levels are associated with impaired b-cell function, raised glucose levels, insulin resistance, and type 2 diabetes (T2D). Studies of the insulin processing pathway could provide new insights about T2D pathophysiology. RESEARCH DESIGN AND METHODS - We have conducted a meta-analysis of genome-wide association tests of ;2.5 million genotyped or imputed single nucleotide polymorphisms (SNPs) and fasting proinsulin levels in 10,701 nondiabetic adults of European ancestry, with follow-up of 23 loci in up to 16,378 individuals, using additive genetic models adjusted for age, sex, fasting insulin, and study-specific covariates. RESULTS - Nine SNPs at eight loci were associated with proinsulin levels (P < 5 × 10-8). Two loci (LARP6 and SGSM2) have not been previously related to metabolic traits, one (MADD) has been associated with fasting glucose, one (PCSK1) has been implicated in obesity, and four (TCF7L2, SLC30A8, VPS13C/ C2CD4A/B, and ARAP1, formerly CENTD2) increase T2D risk. The proinsulin-raising allele of ARAP1 was associated with a lower fasting glucose (P = 1.7 3 10-4), improved b-cell function (P = 1.1 × 10-5), and lower risk of T2D (odds ratio 0.88; P = 7.8 × 10-6). Notably, PCSK1 encodes the protein prohormone convertase 1/3, the first enzyme in the insulin processing pathway. A genotype score composed of the nine proinsulin-raising alleles was not associated with coronary disease in two large case-control datasets. CONCLUSIONS - We have identified nine genetic variants associated with fasting proinsulin. Our findings illuminate the biology underlying glucose homeostasis and T2D development in humans and argue against a direct role of proinsulin in coronary artery disease pathogenesis

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Background After acute coronary syndrome, diabetes conveys an excess risk of ischaemic cardiovascular events. A reduction in mean LDL cholesterol to 1.4-1.8 mmol/L with ezetimibe or statins reduces cardiovascular events in patients with an acute coronary syndrome and diabetes. However, the efficacy and safety of further reduction in LDL cholesterol with an inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9) after acute coronary syndrome is unknown. We aimed to explore this issue in a prespecified analysis of the ODYSSEY OUTCOMES trial of the PCSK9 inhibitor alirocumab, assessing its effects on cardiovascular outcomes by baseline glycaemic status, while also assessing its effects on glycaemic measures including risk of new-onset diabetes

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab.

Background: Apolipoprotein B (apoB) provides an integrated measure of atherogenic risk. Whether apoB levels and apoB lowering hold incremental predictive information on residual risk after acute coronary syndrome beyond that provided by low-density lipoprotein cholesterol is uncertain. Methods: The ODYSSEY OUTCOMES trial (Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab) compared the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab with placebo in 18 924 patients with recent acute coronary syndrome and elevated atherogenic lipoproteins despite optimized statin therapy. Primary outcome was major adverse cardiovascular events (MACE; coronary heart disease death, nonfatal myocardial infarction, fatal/nonfatal ischemic stroke, hospitalization for unstable angina). Associations between baseline apoB or apoB at 4 months and MACE were assessed in adjusted Cox proportional hazards and propensity score–matched models. Results: Median follow-up was 2.8 years. In proportional hazards analysis in the placebo group, MACE incidence increased across increasing baseline apoB strata (3.2 [95% CI, 2.9–3.6], 4.0 [95% CI, 3.6–4.5], and 5.5 [95% CI, 5.0–6.1] events per 100 patient-years in strata 35–<50, and ≤35 mg/dL, respectively). Compared with propensity score–matched patients from the placebo group, treatment hazard ratios for alirocumab also decreased monotonically across achieved apoB strata. Achieved apoB was predictive of MACE after adjustment for achieved low-density lipoprotein cholesterol or non–high-density lipoprotein cholesterol but not vice versa. Conclusions: In patients with recent acute coronary syndrome and elevated atherogenic lipoproteins, MACE increased across baseline apoB strata. Alirocumab reduced MACE across all strata of baseline apoB, with larger absolute reductions in patients with higher baseline levels. Lower achieved apoB was associated with lower risk of MACE, even after accounting for achieved low-density lipoprotein cholesterol or non–high-density lipoprotein cholesterol, indicating that apoB provides incremental information. Achievement of apoB levels as low as ≤35 mg/dL may reduce lipoprotein-attributable residual risk after acute coronary syndrome. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT01663402.gov; Unique identifier: NCT01663402.URL: https://www

Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

non present